Grid Dynamics to Unveil Robotic Inspection Solution at Automatica 2025
San Ramon, Calif., United States:
Key Takeaways: At Automatica 2025, Grid Dynamics will present TPGen—an AI robotic solution developed in partnership with Wandelbots to automate industrial robotic workflows that involve complex programming.
The new solution dramatically reduces programming time—transforming what typically takes weeks of manual robot programming and analysis into automated processes completed in minutes through automatic tool-path generation based on CAD models.
TPGen is built on top of the Wandelbots NOVA platform which enables seamless integration with a broad range of robotic manipulators.
Grid Dynamics Holdings, Inc. (Nasdaq: GDYN) (Grid Dynamics)—a leading provider of technology consulting, platform and product engineering, AI, and digital‑engagement services—today announced it will showcase its TPGen robotic solution at Automatica 2025 , the world's leading event for smart automation and robotics taking place in Munich, Germany from June 24-27, 2025. The TPGen solution from Grid Dynamics, developed in collaboration with robotics industry partner Wandelbots , represents a major advancement in streamlining robotic inspection workflows for welding, gluing, and surface processing applications for manufacturers worldwide.
Analyzing workpiece geometries, planning the scanning processes, and creating tool-paths are often a bottleneck in applications that involve robotic inspection of weld, seams, and surfaces. These steps might take significant time increasing both the time-to-market and the inspection costs. By eliminating the need for manual analysis and tool-path creation, TPGen enables manufacturers to reduce analysis and programming time, cut operational costs and overhead, lower energy consumption, and shorten time-to-market. The TPGen solution runs on top of Wandelbots' NOVA platform, offering an app for seamless and highly automated feasibility analysis, tool-path generation, and trajectory execution.
'TPGen represents a major shift in how manufacturers approach robot programming for inspection use cases,' said Ilya Katsov, CTO, Americas for Grid Dynamics. 'By automatically creating and optimizing tool-paths from CAD models and enabling truly automated workflows, we're helping our clients reduce analysis time from weeks to minutes while significantly lowering operational costs and energy consumption.'
'Wandelbots empowers partners and customers to transform robotic automation into intelligent, reusable, and scalable solutions,' said Katharina Jessa, Chief Revenue Officer at Wandelbots. 'TPGen by Grid Dynamics is a compelling example of what becomes possible with our platform — automating robot path planning for complex inspection tasks, drastically reducing engineering time and enabling flexible deployment across robot brands. It reflects the power of software-first innovation in solving high-impact industrial challenges.'
TPGen capabilities include: Generate tool-paths automatically: Create and optimize tool-paths from CAD models within minutes—even for highly complex geometries—eliminating the need for manual analysis and programming.
Analyze feasibility instantly: Perform automatic feasibility analysis based on workpiece CAD models to streamline planning and reduce setup time.
Optimize processes intelligently: Minimize cycle time, reduce energy consumption, and refine execution plans based on quality metrics and real-time feedback.
Integrate seamlessly: Connect with major robotic arms and camera systems through a hardware-agnostic design.
Leverage advanced computer vision solutions: Support integration with custom or third-party data and image analytics solutions through a flexible architecture.
Industry professionals and manufacturers interested in experiencing TPGen firsthand are invited to visit Grid Dynamics at Automatica 2025 at Wandelbots' Booth at B6.308. Live demonstrations will showcase the solution's capabilities across various inspection scenarios, highlighting its potential to transform manufacturing operations. Visit this page to learn more information about Grid Dynamics' smart manufacturing and robotics solutions.
About Grid Dynamics
Grid Dynamics (Nasdaq: GDYN) is a leading provider of technology consulting, platform and product engineering, AI, and digital engagement services. Fusing technical vision with business acumen, we solve the most pressing technical challenges and enable positive business outcomes for enterprise companies undergoing business transformation. A key differentiator for Grid Dynamics is our 8 years of experience and leadership in enterprise AI , supported by profound expertise and ongoing investment in data and ML platform engineering , cloud platform and product engineering , IoT and edge computing , and digital engagement services . Founded in 2006, Grid Dynamics is headquartered in Silicon Valley with offices across the Americas, Europe, and India. Follow us on LinkedIn .
About Wandelbots
Wandelbots empowers enterprises to transform industrial robotics into software-defined, continuously optimizing systems. With its unified platform – including the Wandelbots NOVA Cloud, the Developer Portal and the Wandelbots NOVA Operating System – manufacturing companies automate faster, optimize smarter, and scale global operations with confidence. For more information, visit www.wandelbots.com and follow us on LinkedIn .
Forward-Looking Statements
This communication contains 'forward-looking statements' within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 that are not historical facts, and involve risks and uncertainties that could cause actual results of Grid Dynamics to differ materially from those expected and projected. These forward-looking statements can be identified by the use of forward-looking terminology, including the words 'believes,' 'estimates,' 'anticipates,' 'expects,' 'intends,' 'plans,' 'may,' 'will,' 'potential,' 'projects,' 'predicts,' 'continue,' or 'should,' or, in each case, their negative or other variations or comparable terminology. These forward-looking statements include, without limitation, quotations and statements regarding the expected benefits of our capabilities and our company's future growth including with customers, the TPGen Robotic Solution, and GigaCube strategy.
These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Most of these factors are outside Grid Dynamics' control and are difficult to predict. Factors that may cause such differences include, but are not limited to our ability to achieve its expected benefits, as well as any factors limiting our capabilities, the benefits of our services and products, and our company's growth strategy.
Grid Dynamics cautions that the foregoing list of factors is not exclusive. Grid Dynamics cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. Grid Dynamics does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions or circumstances on which any such statement is based. Further information about factors that could materially affect Grid Dynamics, including its results of operations and financial condition, is set forth under the 'Risk Factors' section of Grid Dynamics' annual report on Form 10-K filed February 27, 2025, and in other periodic filings Grid Dynamics makes with the SEC.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250619973142/en/
Disclaimer: The above press release comes to you under an arrangement with Business Wire. Business Upturn takes no editorial responsibility for the same.
Ahmedabad Plane Crash
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
26 minutes ago
- Business Upturn
INVESTOR DEADLINE: Rocket Pharmaceuticals, Inc. (RCKT) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
SAN DIEGO, June 20, 2025 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) securities between February 27, 2025 and May 26, 2025, inclusive (the 'Class Period'), have until August 11, 2025 to seek appointment as lead plaintiff of the Rocket Pharmaceuticals class action lawsuit. Captioned Ho v. Rocket Pharmaceuticals, Inc. , No. 25-cv-10049 (D.N.J.), the Rocket Pharmaceuticals class action lawsuit charges Rocket Pharmaceuticals as well as one of Rocket Pharmaceuticals' top executives with violations of the Securities Exchange Act of 1934. If you suffered substantial losses and wish to serve as lead plaintiff of the Rocket Pharmaceuticals class action lawsuit, please provide your information here: You can also contact attorneys J.C. Sanchez or Jennifer N. Caringal of Robbins Geller by calling 800/449-4900 or via e-mail at [email protected]. CASE ALLEGATIONS: Rocket Pharmaceuticals operates as a late-stage biotechnology company that focuses on developing gene therapies for rare and devastating diseases. The Rocket Pharmaceuticals class action lawsuit alleges that defendants provided investors with material information concerning Rocket Pharmaceuticals' Phase 2 pivotal trial of RP-A501 for the treatment of Danon disease while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of RP-A501's safety and clinical trial protocol; notably, that Rocket Pharmaceuticals knew Serious Adverse Events, including death of participants enrolled in the study, were a risk. In particular, Rocket Pharmaceuticals amended the trial's protocol to introduce a novel immunomodulatory agent to the pretreatment regimen without providing this critical update to shareholders, according to the complaint. The Rocket Pharmaceuticals class action lawsuit further alleges that on May 27, 2025, Rocket Pharmaceuticals announced that the U.S. Food and Drug Administration placed a clinical hold on the RP-A501 Phase 2 pivotal study after at least one patient suffered a Serious Adverse Event, ultimately, death, while enrolled in the study following a substantive amendment to the protocol that Rocket Pharmaceuticals failed to disclose to investors at the time management made the revision. On this news, the price of Rocket Pharmaceuticals stock fell, according to the complaint. THE LEAD PLAINTIFF PROCESS: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased or acquired Rocket Pharmaceuticals securities during the Class Period to seek appointment as lead plaintiff in the Rocket Pharmaceuticals class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other class members in directing the Rocket Pharmaceuticals class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the Rocket Pharmaceuticals class action lawsuit. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the Rocket Pharmaceuticals class action lawsuit. ABOUT ROBBINS GELLER: Robbins Geller Rudman & Dowd LLP is one of the world's leading law firms representing investors in securities fraud and shareholder litigation. Our Firm has been ranked #1 in the ISS Securities Class Action Services rankings for four out of the last five years for securing the most monetary relief for investors. In 2024, we recovered over $2.5 billion for investors in securities-related class action cases – more than the next five law firms combined, according to ISS. With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs' firms in the world, and the Firm's attorneys have obtained many of the largest securities class action recoveries in history, including the largest ever – $7.2 billion – in In re Enron Corp. Sec. Litig. Please visit the following page for more information: Past results do not guarantee future outcomes. Services may be performed by attorneys in any of our offices. Contact: Robbins Geller Rudman & Dowd LLP J.C. Sanchez, Jennifer N. Caringal 655 W. Broadway, Suite 1900, San Diego, CA 92101 800-449-4900 [email protected]
Yahoo
39 minutes ago
- Yahoo
Tesla (TSLA) Stock Rated Overweight as Robotaxi Launch Nears
Tesla, Inc. (NASDAQ:) is one of the 10 AI Stocks Getting Wall Street's Attention. On June 16, Cantor Fitzgerald analyst Andres Sheppard reiterated an 'Overweight' rating on the stock with a $355.00 price target. The rating affirmation comes as Tesla continues to test its unsupervised self-driving Model Y vehicles in Austin, Texas. This testing comes ahead of its robotaxi release, scheduled for June, targeting June 22nd for the release. CEO Elon Musk had previously announced that the initial robotaxi rollout would include a 'modest number of vehicles' before it expands to other cities. By 2026, the company plans to reveal its cybercab, which is expected to have no steering wheel or pedals. Tesla's Full Self-Driving (FSD) technology with supervision has garnered over 3.5 billion cumulative miles as of the first quarter of 2025. The firm rolled out FSD in China during the first quarter, anticipating a launch in Europe during the first half of 2025, pending regulatory approval. Tesla, Inc. (NASDAQ:TSLA) is an automotive and clean energy company that leverages advanced artificial intelligence in its autonomous driving technology and robotics initiatives.
Yahoo
40 minutes ago
- Yahoo
Why Couchbase Stock Is Skyrocketing Today
Couchbase announced that it's on track to be acquired by Haveli Investments. The company is set to be acquired at a $1.5 billion valuation that works out to a buyout price of $24.50 per share. The acquisition looks set to close in the very near future, and Couchbase stock is now valued very close to the buyout price. 10 stocks we like better than Couchbase › Couchbase (NASDAQ: BASE) stock is seeing a huge jump in Friday's trading following news of a buyout for the company. The software specialist's share price was up 30% as of 3:25 p.m. ET. Before market open this morning, Couchbase published a press release announcing that it had entered into an agreement to be acquired by Haveli Investments. The deal will see Couchbase acquired at a $1.5 billion valuation, representing a 29% premium compared to the company's price at market close on June 18. With the company valued at $1.5 billion in the acquisition, shareholders will receive $24.50 per share as part of the all-cash buyout. Couchbase will become a privately held company after the deal is completed. The company says that the buyout is expected to close before the end of this month, and Haveli indicated that Couchbase's strengths in artificial intelligence (AI) development tools was a key factor in its acquisition move. Couchbase says that the acquisition agreement includes a "go-shop" period, which will allow the company to explore other buyout offers before 11:59 p.m. ET on June 23. While this potentially leaves the door open for another suitor to come in with a higher buyout offer, it's also an extremely short window for another potential buyer to come in with their own buyout terms. Couchbase's press release for its acquisition by Haveli Investments suggests that it's extremely likely that the purchase will be completed after this coming Monday. As of this writing, the company's share price has risen to be roughly in line with the scheduled buyout price -- which suggests that there's very little reason for new investors to enter the stock at this point. Before you buy stock in Couchbase, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Couchbase wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $659,171!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $891,722!* Now, it's worth noting Stock Advisor's total average return is 995% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 9, 2025 Keith Noonan has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Why Couchbase Stock Is Skyrocketing Today was originally published by The Motley Fool Sign in to access your portfolio
